Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Adipose-derived stromal cells enhance auditory neuron survival in an animal model of sensory hearing loss.

Schendzielorz P, Vollmer M, Rak K, Wiegner A, Nada N, Radeloff K, Hagen R, Radeloff A.

Cytotherapy. 2017 Oct;19(10):1197-1207. doi: 10.1016/j.jcyt.2017.07.007. Epub 2017 Aug 14.

PMID:
28818455
2.

Multichannel cochlear implant for selective neuronal activation and chronic use in the free-moving Mongolian gerbil.

Wiegner A, Wright CG, Vollmer M.

J Neurosci Methods. 2016 Nov 1;273:40-54. doi: 10.1016/j.jneumeth.2016.08.006. Epub 2016 Aug 9.

PMID:
27519925
3.

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Logigian EL, Martens WB, Moxley RT 4th, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, Moxley RT 3rd.

Neurology. 2010 May 4;74(18):1441-8. doi: 10.1212/WNL.0b013e3181dc1a3a.

4.

Evoked myotonia can be "dialed-up" by increasing stimulus train length in myotonic dystrophy type 1.

Logigian EL, Twydell P, Dilek N, Martens WB, Quinn C, Wiegner AW, Heatwole CR, Thornton CA, Moxley RT 3rd.

Muscle Nerve. 2010 Feb;41(2):191-6. doi: 10.1002/mus.21481.

5.

Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).

Moxley RT 3rd, Logigian EL, Martens WB, Annis CL, Pandya S, Moxley RT 4th, Barbieri CA, Dilek N, Wiegner AW, Thornton CA.

Muscle Nerve. 2007 Sep;36(3):320-8.

PMID:
17587223
6.

Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1.

Logigian EL, Blood CL, Dilek N, Martens WB, Moxley RT 4th, Wiegner AW, Thornton CA, Moxley RT 3rd.

Muscle Nerve. 2005 Jul;32(1):35-42.

PMID:
15880468
7.

Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.

Logigian EL, Moxley RT 4th, Blood CL, Barbieri CA, Martens WB, Wiegner AW, Thornton CA, Moxley RT 3rd.

Neurology. 2004 Apr 13;62(7):1081-9.

PMID:
15079005
8.

Efficacy of an implanted neuroprosthesis for restoring hand grasp in tetraplegia: a multicenter study.

Peckham PH, Keith MW, Kilgore KL, Grill JH, Wuolle KS, Thrope GB, Gorman P, Hobby J, Mulcahey MJ, Carroll S, Hentz VR, Wiegner A; Implantable Neuroprosthesis Research Group.

Arch Phys Med Rehabil. 2001 Oct;82(10):1380-8.

PMID:
11588741
9.
10.

Accuracy of motor responses in subjects with and without control of antagonist muscle.

Wierzbicka MM, Wiegner AW.

J Neurophysiol. 1996 Jun;75(6):2533-41.

PMID:
8793762
11.

Discharge properties of single motor units in patients with spinal cord injuries.

Wiegner AW, Wierzbicka MM, Davies L, Young RR.

Muscle Nerve. 1993 Jun;16(6):661-71.

PMID:
8502264
12.

Can basic science help improve arm function in C5 tetraplegia?

Wiegner AW.

J Am Paraplegia Soc. 1993 Apr;16(2):75. No abstract available.

PMID:
8496696
13.

Portable system for quantifying motor abnormalities in Parkinson's disease.

Ghika J, Wiegner AW, Fang JJ, Davies L, Young RR, Growdon JH.

IEEE Trans Biomed Eng. 1993 Mar;40(3):276-83.

PMID:
8335331
14.

Variation in firing order of human soleus motoneurons during voluntary and reflex activation.

Davies L, Wiegner AW, Young RR.

Brain Res. 1993 Jan 29;602(1):104-10.

PMID:
8448646
15.

Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.

Herold KC, Bluestone JA, Montag AG, Parihar A, Wiegner A, Gress RE, Hirsch R.

Diabetes. 1992 Mar;41(3):385-91.

PMID:
1532369
16.

Kinematic models and human elbow flexion movements: quantitative analysis.

Wiegner AW, Wierzbicka MM.

Exp Brain Res. 1992;88(3):665-73.

PMID:
1587325
17.

Treatment of spasticity with botulinum toxin.

Borodic GE, Ferrante R, Wiegner AW, Young RR.

Ann Neurol. 1992 Jan;31(1):113. No abstract available.

PMID:
1543342
18.

Effects of weak antagonist on fast elbow flexion movements in man.

Wierzbicka MM, Wiegner AW.

Exp Brain Res. 1992;91(3):509-19.

PMID:
1483523
19.

Abnormal most-rapid isometric contractions in patients with Parkinson's disease.

Wierzbicka MM, Wiegner AW, Logigian EL, Young RR.

J Neurol Neurosurg Psychiatry. 1991 Mar;54(3):210-6.

20.

Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy.

Borodic GE, Cozzolino D, Ferrante R, Wiegner AW, Young RR.

Ophthalmic Plast Reconstr Surg. 1991;7(1):54-60.

PMID:
1708272

Supplemental Content

Support Center